- CUE Dashboard
- Financials
- Filings
-
Holdings
- Transcripts
- ETFs
- Insider
- Institutional
- Shorts
-
10-K/A Filing
Cue Biopharma (CUE) 10-K/A2019 FY Annual report (amended)
Filed: 29 Apr 20, 4:55pm
Exhibit 31.1
CERTIFICATION OF THE PRINCIPAL EXECUTIVE OFFICER
PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002
I, Daniel R. Passeri, certify that:
1. | I have reviewed this Amendment No. 2 to Annual Report on Form10-K of Cue Biopharma, Inc.; and |
2. | Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report. |
Date: April 29, 2020
Cue Biopharma, Inc. | ||
By: | /s/ Daniel R. Passeri | |
Daniel R. Passeri Chief Executive Officer (Principal Executive Officer) |
We use cookies on this site to provide a more responsive and personalized service. Continuing to browse, clicking I Agree, or closing this banner indicates agreement. See our Cookie Policy for more information.